Relmada Therapeutics Ratios (2012-2026) | RLMD

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)
EBT Margin (Quarter)
EBIT Margin (Quarter)
EBITDA Margin (Quarter)
Operating Margin (Quarter)
Net Margin (Quarter)
FCF Margin (Quarter)
Efficiency
Assets Average (Quarter)	107.32M	100.85M	157.13M	224.57M	220.79M	201.45M	170.01M	144.24M	128.80M	115.59M	103.35M	90.98M	77.72M	63.38M	50.77M	36.75M	24.40M	18.00M	54.44M	164.68M
Equity Average (Quarter)	94.00M	84.77M	140.48M	209.33M	203.62M	181.60M	153.39M	132.95M	118.40M	106.03M	93.04M	78.70M	66.77M	54.56M	41.57M	28.98M	19.19M	12.71M	47.99M	152.62M
Invested Capital (Quarter)	96.85M	72.69M	208.26M	210.40M	196.85M	166.34M	140.44M	125.47M	111.34M	100.73M	85.36M	72.05M	61.49M	47.63M	35.52M	22.44M	15.95M	9.47M	86.51M	218.73M
Asset Utilization Ratio (Quarter)
Leverage & Solvency
Interest Coverage Ratio (Quarter)
Debt to Equity (Quarter)
Debt Ratio (Quarter)
Equity Ratio (Quarter)	0.87	0.80	0.93	0.93	0.91	0.89	0.92	0.93	0.91	0.92	0.87	0.85	0.87	0.85	0.78	0.81	0.76	0.64	0.92	0.93
Times Interest Earned (Quarter)
Valuation
Enterprise Value (Quarter)	-109.07M	-88.09M	-211.91M	-220.65M	-211.96M	-184.15M	-148.32M	-132.44M	-118.53M	-106.27M	-96.32M	-83.61M	-70.44M	-54.12M	-44.91M	-27.06M	-20.62M	-13.89M	-93.01M	-233.96M
Return Ratios
Return on Sales (Quarter)
Return on Capital Employed (Quarter)	-93.12%	-136.12%	-88.48%	-67.70%	-79.58%	-86.75%	-102.35%	-112.65%	-111.45%	-107.84%	-113.76%	-125.34%	-133.95%	-165.75%	-207.24%	-251.04%	-366.11%	-451.66%	-123.10%	-39.75%
Return on Assets (Quarter)	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.02%	-0.02%	-0.03%	-0.03%	-0.01%	0.00%
Return on Equity (Quarter)	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.02%	-0.02%	-0.03%	-0.04%	-0.04%	-0.01%	0.00%

Research Tools

Relmada Therapeutics Ratios (2012-2026) | RLMD

Create an account

Sign In

Reset Password